Inflammation in plaque rupture: An active participant or an invited guest?

American Journal of Critical Care

Volumn 7, Issue 2, 1998, Pages 153-161

  Futterman, Laurie G ^a   Lemberg, Louis ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; INFLAMMATION; PATHOLOGY; REVIEW; RUPTURE;

CORONARY ARTERIOSCLEROSIS; HUMANS; INFLAMMATION; RUPTURE, SPONTANEOUS;

EID: 0032012666     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc1998.7.2.153     Document Type: Article

References (38)

1. Alexander W. Inflammation and coronary artery disease. N Engl J Med. 1994;331:468-469.
2. Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave myocardial infarction. Circulation. 1997;96:778-784.
3. Maseri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med. 1997;336:1014-1015.
4. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
5. Koenig W, Froehlich M, Sund M, et al. C-reactive protein (CRP) predicts risk of coronary heart disease (CHD) in healthy middle-aged men: results from the MONICA-Augsburg Cohort Study, 1984/85-1992. Circulation. 1997;96(8):I-99. Abstract.
6. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-435.
7. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298.
8. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
9. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988;58:249-261.
10. Renaud S, deLorgeril M, Delaye J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995;61(suppl): 1360S-7S. Abstract.
11. O'Keefe JH, Conn RD, Lavie CL, Bateman TM. The new paradigm for coronary artery disease: altering risk factors. Mayo Clin Proc. 1996;71:957-965.
12. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J. β-blockers and sudden cardiac death. Ann Intern Med. 1995;123:358-367.
13. Forrester JS, Merz CN, Bush T, et al. Task force 4: efficacy of risk factor management. J Am Coll Cardiol. 1996;27:964-1047.
14. Futterman LG, Lemberg L. Sudden cardiac death-preventable -reversible. Am J Crit Care. 1997;6:472-482.
15. Stephens NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
16. Futterman LG, Lemberg L. Harnessing the platelet. Am J Crit Care. 1997;6:406-414.
17. Azar RR, Waters DD. The inflammatory etiology of unstable angina. Am Heart J. 1996;132:1101-1105.
18. Basha BJ, Sowers JR. Atherosclerosis: an update. Am Heart J. 1995;131:1192-1202.
19. Benamer H, Benessiano J, Gaultier CJ, et al. Prognostic markers in unstable angina: the relationship between troponin I and c-reactive protein. J Am Coll Cardiol 1997:233A. Abstract #970-39.
20. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 1990;65:168-172.
21. de Maat M, Pietersma A, Kafflard M, et al. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis. 1996;121:185-191.
22. de Zwaan C, Bar F, Gorgels A, Wellens H. Unstable angina: are we able to recognize high-risk patients? Chest. 1997;112:244-250.
23. DiSciascio G, Cowley MJ, Goudreau E, et al. Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional atherectomy: in vivo evidence of thrombosis, ulceration, and inflammation. Am Heart J. 1994;128:419-422.
24. Haught WH, Mansour M, Rothlein R, et al. Alterations in circulating intercellular adhesion molecule-1 and L-selection: further evidence for chronic inflammation in ischemic heart disease. Am Heart J. 1996;132:1-8.
25. Held C, Hjemdahl P, Rehnquist N, et al. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS): a comparison with healthy controls. J Intern Med. 1997;241:59-69.
26. Kendall MJ. Prevention of sudden death with β-blockers. Adv Cardiovasc Med. 1996;3:1-6.
27. Lip GYN, Beevers DG. Can we treat coronary heart disease with antibiotics? Lancet. 1997;350:378-380.
28. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of c-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
29. Luigi LG, Gallimore MB, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. Circulation. 1997;95:1806-1812.
30. Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J. 1993;14(suppl K):12-16.
31. Ramirez JA. Isolation of Chlamydia pneumonia from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125:979-982.
32. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
33. Saikku P. Chlamydia pneumonia infection as a risk factor in acute myocardial infarction. Eur Heart J. 1993;14(suppl K):62-65.
34. Schroeder AP, Falk E. Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin. 1996;14:211-218.
35. Simon AD, Yazdani S, Wang W, et al. Inflammatory cytokines in stable vs unstable angina. J Am Coll Cardiol 1997:233A. Abstract #970-38.
36. Sumpter MT, Dunn MI. Is coronary artery disease an infectious disease? Chest. 1997;112:302-303.
37. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997;349:1391-1392.
38. van der Wal A, Becker AE, van der Loos C, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.